# Real-Time Oncology Review (RTOR) :  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/real-time-oncology-review-rtor-guidance-for-industry/5d600007-ac00-4be9-8047-0a2e0cfaeca2

> FDA guidance document: Real-Time Oncology Review (RTOR) :  Guidance for Industry. Issue date: November 07, 2023. Get complete insights and analysis.

---

## Details

- Title: Real-Time Oncology Review (RTOR) :  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2023-11-07
- Last Changed: 2023-11-07
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-0823">FDA-2022-D-0823</a>

## Related Documents

- [M10 Bioanalytical Method Validation and Study Sample Analysis](https://www.globalkeysolutions.net/guidances/guidance-document/m10-bioanalytical-method-validation-and-study-sample-analysis/ae7fec2e-4331-4dbe-a88a-8bb7bbd7e464)
- [Q9(R1) Quality Risk Management](https://www.globalkeysolutions.net/guidances/guidance-document/q9r1-quality-risk-management/3a048fa1-d9e8-42c1-a9f5-9f508b708dad)
- [Benefit-Risk Assessment for New Drug and Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/benefit-risk-assessment-for-new-drug-and-biological-products/90bf84f4-05cf-4617-b13d-bbb345349aed)